[Subcutaneous immunoglobulin infusion in antibody deficiency substitution of a patient sensitized to intravenous immunoglobulins. Case report].
Patients with severe form of common variable immunodeficiency require chronic immunoglobulin substitution. However, intravenous Ig administration may not be possible in some of them because of serious anaphylactoid reactions. It has been suggested that such patients may tolerate well Ig administration by subcutaneous infusion. A case is described (originally with IgG level of 53 mg/dl) who reacted with anaphylactic shock to intravenous immunoglobulin and now for more than 7 months at 1-2 week intervals receives immunoglobulin by subcutaneous infusion without any adverse reactions and maintaining IgG level above 400 mg/dl. In contrast to the period proceeding immunoglobulin substitution, the patient remains free of bacterial infection during last 7 months.
Wiktor-Jedrzejczak
W
W
Zakładu Immunologii CSK WAM w Warszawie.
Szwech
P
P
Kruszewski
A A
AA
Raczka
A
A
Zakrzewski
A
A
Kłos
M
M
D017074:Common Variable Immunodeficiency / Q000628:therapy*; D005260:Female; D006801:Humans; D007116:Immunization, Passive; D007074:Immunoglobulin G / Q000008:administration & dosage* / Q000032:analysis; D007279:Injections, Subcutaneous; D008875:Middle Aged; D016896:Treatment Outcome
D007074:Immunoglobulin G